Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$9.08
-0.11-1.2%
Last update: Aug 10, 8:58 AM
Ocular Therapeutix Inc
OCULNASDAQ
Earnings: Q2 2026 Earnings were released on Mon Aug 3rd, before the market open
Ocular Therapeutix Market Sentiment
Market sentiment signals for Ocular Therapeutix (OCUL): analyst consensus, short interest, options flow and insider activity.
Key Signals
Analyst Consensus▲ Buy
Short Interest▼ 14.6% short float
Options Flow▲ 0.77 P/C ratio
Insider Activity— N/A
Analyst Consensus
Buy
16 analysts
Options Flow (P/C)
0.77
More calls — Bullish
393 calls · 304 puts
Avg Consensus PT
$23
+150.3%
Highest Price Target
$31
+241.4%
Piper Sandler
Lowest Price Target
$15
+65.2%
Piper Sandler
Short Interest
14.6%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
Recent Analyst Actions
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | Chardan Capital | Andreas Argyrides— | +153.3% | $23 → $23 | Maintained | Buy |
| Jun 25, 2026 | Chardan Capital | Andreas Argyrides— | +153.3% | $21 → $23 | Maintained | Buy |
